India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:540691 has a market cap or net worth of INR 709.86 billion.
| Market Cap | 709.86B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Monday, August 4, 2025.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 2.61B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 816.84M |
Valuation Ratios
The trailing PE ratio is 20.83 and the forward PE ratio is 16.98.
| PE Ratio | 20.83 |
| Forward PE | 16.98 |
| PS Ratio | 2.38 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 4.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.97M |
| Profits Per Employee | 568,093 |
| Employee Count | 46,688 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:540691 has paid 15.01 billion in taxes.
| Income Tax | 15.01B |
| Effective Tax Rate | 30.15% |
Stock Price Statistics
The stock price has increased by +31.12% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +31.12% |
| 50-Day Moving Average | 261.08 |
| 200-Day Moving Average | 205.12 |
| Relative Strength Index (RSI) | 54.24 |
| Average Volume (20 Days) | 254,556 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540691 had revenue of INR 297.99 billion and earned 34.09 billion in profits. Earnings per share was 12.95.
| Revenue | 297.99B |
| Gross Profit | 80.24B |
| Operating Income | 45.33B |
| Pretax Income | 49.76B |
| Net Income | 34.09B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 12.95 |
Balance Sheet
The company has 169.65 billion in cash and 1.40 trillion in debt, giving a net cash position of -1,232.02 billion.
| Cash & Cash Equivalents | 169.65B |
| Total Debt | 1.40T |
| Net Cash | -1,232.02B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 323.47B |
| Book Value Per Share | 116.57 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 26.93%, with operating and profit margins of 15.21% and 11.44%.
| Gross Margin | 26.93% |
| Operating Margin | 15.21% |
| Pretax Margin | 16.70% |
| Profit Margin | 11.44% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:540691 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.80% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |